{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:40Z","timestamp":1789430440183,"version":"build-2803163510"},"reference-count":24,"publisher":"Centers for Disease Control MMWR Office","issue":"49","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm7249a3","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T16:27:27Z","timestamp":1701966447000},"page":"1327-1330","source":"Crossref","is-referenced-by-count":19,"title":["Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2023"],"prefix":"10.15585","volume":"72","author":[{"given":"Sarah","family":"Kidd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janell","family":"Routh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybil","family":"Cineas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Bahta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R1","unstructured":"Hall E, Wodi AP, Hamborsky J, , eds. Epidemiology and prevention of vaccine-preventable diseases. 14th ed. Washington, DC: CDC, Public Health Foundation; 2021."},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R2","first-page":"1","article-title":"Poliomyelitis prevention in the United States: updated recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"49","author":"Prevots","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R3","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.15585\/mmwr.mm7133e2","article-title":"Public health response to a case of paralytic poliomyelitis in an unvaccinated person and detection of poliovirus in wastewater\u2014New York, June\u2013August 2022.","volume":"71","author":"Link-Gelles","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R4","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.15585\/mmwr.mm7144e2","article-title":"Wastewater testing and detection of poliovirus type 2 genetically linked to virus isolated from a paralytic polio case\u2014New York, March 9\u2013October 11, 2022.","volume":"71","author":"Ryerson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R5","unstructured":"New York State Department of Health. Poliovirus wastewater surveillance report. Albany, NY: New York State Department of Health; 2023. Accessed July 27, 2023. https:\/\/www.health.ny.gov\/diseases\/communicable\/polio\/docs\/waste_water_surveillance_report.pdf"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.15585\/mmwr.mm7202a3","article-title":"Vaccination coverage by age 24 months among children born during 2018\u20132019\u2014National Immunization Survey\u2013Child, United States, 2019\u20132021.","volume":"72","author":"Hill","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1749-6632.1995.tb44462.x","article-title":"Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination.","volume":"754","author":"Sutter","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/00006454-199703000-00011","article-title":"Fifteen years of experience with Vero-produced enhanced potency inactivated poliovirus vaccine.","volume":"16","author":"Vidor","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.coviro.2013.05.007","article-title":"Poliovirus vaccination options for achieving eradication and securing the endgame.","volume":"3","author":"Est\u00edvariz","year":"2013","journal-title":"Curr Opin Virol"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R10","doi-asserted-by":"publisher","first-page":"e1002599","DOI":"10.1371\/journal.ppat.1002599","article-title":"Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge.","volume":"8","author":"Hird","year":"2012","journal-title":"PLoS Pathog"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R11","first-page":"93","article-title":"Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in Kenya.","volume":"70","author":"Kok","year":"1992","journal-title":"Bull World Health Organ"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/infdis\/163.1.1","article-title":"Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines.","volume":"163","author":"Onorato","year":"1991","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R13","unstructured":"Food and Drug Administration. Polio vaccine inactivated. Package insert. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2022. https:\/\/www.fda.gov\/files\/vaccines%2C%20blood%20%26%20biologics\/published\/Package-Insert-IPOL.pdf"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R14","first-page":"145","article-title":"Evaluation of a new combined inactivated DPT-polio vaccine.","volume":"65","author":"Drucker","year":"1986","journal-title":"Dev Biol Stand"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R15","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1542\/peds.107.5.e83","article-title":"Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.","volume":"107","author":"Wattigney","year":"2001","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R16","unstructured":"Polio vaccines [Chapter 7]. In: Stratton KR, Howe CJ, eds. Adverse events associated with childhood vaccines: evidence bearing on causality. Washington, DC: National Academy Press; 1994:187\u2013210."},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R17","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S1473-3099(15)00059-6","article-title":"Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000\u201312.","volume":"15","author":"Iqbal","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1186\/s12889-016-3386-1","article-title":"Seroprevalence of poliovirus antibodies in the United States population, 2009\u20132010.","volume":"16","author":"Wallace","year":"2016","journal-title":"BMC Public Health"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R19","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1016\/j.vaccine.2014.07.088","article-title":"Effect of multiple, simultaneous vaccines on polio seroresponse and associated health outcomes.","volume":"33","author":"Broderick","year":"2015","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R20","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1016\/j.vaccine.2014.05.034","article-title":"Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis) in adults aged \u2265 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.","volume":"32","author":"Dominicus","year":"2014","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R21","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.3390\/vaccines10122160","article-title":"Immunogenicity of catch-up immunization with conventional inactivated polio vaccine among Japanese adults.","volume":"10","author":"Fukushima","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R22","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1016\/j.vaccine.2005.02.013","article-title":"Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.","volume":"23","author":"Grimprel","year":"2005","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.4161\/hv.6.10.12582","article-title":"Humoral immunity of dTap-IPV vaccine (REPEVAX) administered one month after dT-IPV vaccine (REVAXIS) in adults with unknown vaccination history.","volume":"6","author":"Larnaudie","year":"2010","journal-title":"Hum Vaccin"},{"key":"key-10.15585\/mmwr.mm7249a3-202312061331-R24","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.vaccine.2012.12.081","article-title":"Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip) to adults aged \u226560 years: an open-label, randomised trial.","volume":"31","author":"Zimmermann","year":"2013","journal-title":"Vaccine"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T16:27:31Z","timestamp":1701966451000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/72\/wr\/mm7249a3.htm?s_cid=mm7249a3_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":24,"journal-issue":{"issue":"49","published-online":{"date-parts":[[2023,12,8]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm7249a3","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12,8]]},"published":{"date-parts":[[2023,12,8]]}}}